The cholinergic anti-inflammatory pathway: Towards innovative treatment of rheumatoid arthritis

Nature Reviews Rheumatology

Volumn 5, Issue 4, 2009, Pages 229-232

  van Maanen, Marjolein A ^a   Vervoordeldonk, Margriet J ^a   Tak, Paul P ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA-BUNGAROTOXIN RECEPTOR; BUNGAROTOXIN RECEPTOR; NICOTINIC RECEPTOR;

ARTICLE; AUTONOMIC NERVE; CHOLINERGIC NERVE; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

ARTHRITIS, RHEUMATOID; AUTONOMIC PATHWAYS; CHOLINERGIC FIBERS; HUMANS; RECEPTORS, NICOTINIC;

EID: 67650501700     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2009.31     Document Type: Article

References (32)

1. Steinman, L. Elaborate interactions between the immune and nervous systems. Nat. Immunol. 5, 575-581 (2004).
2. Tracey, K. J. The inflammatory reflex. Nature 420, 853-859 (2002).
3. Borovikova, L. V. et al. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405, 458-462 (2000).
4. van der Zanden, E. P, Boeckxstaens, G. E. & de Jonge, W. J. The vagus nerve as a modulator of intestinal inflammation. Neurogastroenterol. Motil. 21, 6-17 (2009).
5. Borovikova, L. V. et al. Role of vagus nerve signaling in CNI-1493-mediated suppression of acute inflammation. Auton. Neurosci. 85, 141-147 (2000).
6. Wang, H. et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421, 384-388 (2003).
7. The, F. O. et al. Activation of the cholinergic anti- inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 133, 1219-1228 (2007).
8. van Westerloo, D. J. et al. The vagus nerve and nicotinic receptors modulate experimental pancreatitis severity in mice. Gastroenterology 130, 1822-1830 (2006).
9. Giebelen, I. A., van Westerloo, D. J., Larosa, G. J., de Vos, A. F & van der Poll, T. Local stimulation of alpha7 cholinergic receptors inhibits LPS-induced TNF-alpha release in the mouse lung. Shock 28, 700-703 (2007).
10. van Maanen, M. A. et al. Stimulation of nicotinic acetylcholine receptors attenuates collagen- induced arthritis in mice. Arthritis Rheum. 60, 114-122 (2009).
11. Waldburger, J. M., Boyle, D. L., Pavlov, V. A., Tracey, K. J. & Firestein, G. S. Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum. 58, 3439-3449 (2008).
12. van Maanen, M. A. et al. The alpha 7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients. Arthritis Rheum. (in press).
13. Stojanovich, L. et al. Cardiovascular autonomic dysfunction in systemic lupus, rheumatoid arthritis, primary Sjogren syndrome and other autoimmune diseases. Lupus 16, 181-185 (2007).
14. Goldstein, R. S. et al. Cholinergic anti- inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol. Med. 13, 210-215 (2007).
15. de Jonge, W. J. & Ulloa, L. The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br. J. Pharmacol. 151, 915-929 (2007).
16. Drisdel, R. C. & Green, W. N. Neuronal alpha- bungarotoxin receptors are alpha7 subunit homomers. J. Neurosci. 20, 133-139 (2000).
17. de Jonge, W. J. et al. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat. Immunol. 6, 844-851 (2005).
18. Walker, J. G. & Smith, M. D. The Jak-STAT pathway in rheumatoid arthritis. J. Rheumatol. 32, 1650-1653 (2005).
19. Wang, H. et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat. Med. 10, 1216-1221 (2004).
20. Villiger, Y. et al. Expression of an alpha7 duplicate nicotinic acetylcholine receptor-related protein in human leukocytes.J. Neuroimmunol. 126, 86-98 (2002).
21. Guarini, S. et al. Efferent vagal fibre stimulation blunts nuclear factor-kappaB activation and protects against hypovolemic hemorrhagic shock. Circulation 107, 1189-1194 (2003).
22. Zhang, P, Han, D., Tang, T., Zhang, X. & Dai, K. Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm. Res. 57, 322-328 (2008).
23. Shafique, S. & Dalsing, M. C. Vagus nerve stimulation therapy for treatment of drug- resistant epilepsy and depression. Perspect. Vasc. Surg. Endovasc. Ther. 18, 323-327 (2006).
24. Carlens, C., Brandt, L., Klareskog, L., Lampa, J. & Askling, J. The inflammatory reflex and risk for rheumatoid arthritis: a case-control study of human vagotomy. Ann. Rheum. Dis. 66, 414-416 (2007).
25. Levin, E. D. & Rezvani, A. H. Development of nicotinic drug therapy for cognitive disorders. Eur. J. Pharmacol. 393, 141-146 (2000).
26. Huang, X., Zheng, F., Stokes, C., Papke, R. L., Zhan, C. G. Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding. J. Med. Chem. 51, 6293-6302 (2008).
27. Kitagawa, H. et al. Safety, pharmacokinetics, and effects on cognitive function of multiple doses of GTS-21 in healthy, male volunteers. Neuropsychopharmacology 28, 542-551 (2003).
28. Huston, J. M. et al. Splenectomy inactivates the cholinergic anti-inflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J. Exp. Med. 203, 1623-1628 (2006).
29. Rosas-Ballina, M. et al. Splenic nerve is required for cholinergic anti-inflammatory pathway control of TNF in endotoxemia. Proc. Natl Acad. Sci. USA 105, 11008-11013 (2008).
30. Pavlov, V. A. et al. Brain acetylcholinesterase activity controls systemic cytokine levels through the cholinergic anti-inflammatory pathway. Brain Behav. Immun. 23, 41-45 (2009).
31. Birks, J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005593. doi:0.1002/14651858.CD005593.
32. Wessler, I. & Kirkpatrick, C. J. Acetylcholine beyond neurons: the non-neuronal cholinergic system in humans. Br. J. Pharmacol. 154, 1558-1571 (2008).